Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Directions in Therapeutics for Huntington Disease
Katya T Potkin, Steven G. Potkin
Future Neurology (2018) Vol. 13, Iss. 2, pp. 101-121
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

New Avenues for the Treatment of Huntington’s Disease
Amy Kim, Kathryn M. Lalonde, Aaron Truesdell, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8363-8363
Open Access | Times Cited: 138
Gene Therapy Tools for Brain Diseases
Selene Ingusci, Gianluca Verlengia, Marie Soukupová, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 143
Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases
Serena Stanga, Anna Caretto, Marina Boido, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3719-3719
Open Access | Times Cited: 74
An RNA-targeting CRISPR–Cas13d system alleviates disease-related phenotypes in Huntington’s disease models
Kathryn H. Morelli, Qian Wu, Maya L. Gosztyla, et al.
Nature Neuroscience (2022) Vol. 26, Iss. 1, pp. 27-38
Open Access | Times Cited: 67
Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities
Lu Yan, Min‐Song Guo, Yue Zhang, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-40
Open Access | Times Cited: 59
Research Evidence of the Role of the Glymphatic System and Its Potential Pharmacological Modulation in Neurodegenerative Diseases
Joji Philip Verghese, Alana Terry, Edoardo Rosario de Natale, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 23, pp. 6964-6964
Open Access | Times Cited: 29
Co-chaperones DNAJA1 and DNAJB6 are critical for regulation of polyglutamine aggregation
Claudio Rodríguez-González, Shiying Lin, Sertan Arkan, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 48
Endocannabinoid Modulation in Neurodegenerative Diseases: In Pursuit of Certainty
Alexandru Vasincu, Răzvan-Nicolae Rusu, Daniela Carmen Ababei, et al.
Biology (2022) Vol. 11, Iss. 3, pp. 440-440
Open Access | Times Cited: 24
Protective Effects of Polysaccharides in Neurodegenerative Diseases
Yinying Wang, Rongsha Chen, Zhongshan Yang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 24
Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7
Anna Niewiadomska-Cimicka, Yvon Trottier
Neurotherapeutics (2019) Vol. 16, Iss. 4, pp. 1074-1096
Open Access | Times Cited: 41
Copper enhances aggregational toxicity of mutant huntingtin in a Drosophila model of Huntington's Disease
Amanda G. Lobato, Natalie Ortiz-Vega, Yi Zhu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2023) Vol. 1870, Iss. 1, pp. 166928-166928
Closed Access | Times Cited: 11
Protein modification in neurodegenerative diseases
Shahin Ramazi, Maedeh Dadzadi, Mona Darvazi, et al.
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 4
Decoding Neurodegeneration: A Review of Molecular Mechanisms and Therapeutic Advances in Alzheimer’s, Parkinson’s, and ALS
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12613-12613
Open Access | Times Cited: 4
Nutrition and Huntington’s Disease– A Review of Current Practice and Theory
Ann Gaba
Current Nutrition Reports (2025) Vol. 14, Iss. 1
Open Access
Polyamines signalling pathway: A key player in unveiling the molecular mechanisms underlying Huntington’s disease
Amit Shiwal, Dhanshree Nibrad, Manasi Tadas, et al.
Neuroscience (2025)
Closed Access
Lipid nanoparticle (LNP) mediated mRNA delivery in neurodegenerative diseases
Seyedeh Ghazal Moosavi, Niloufar Rahiman, Mahmoud Reza Jaafari, et al.
Journal of Controlled Release (2025), pp. 113641-113641
Closed Access
Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex
Tiziana Petrozziello, Alexandra N. Mills, Christine A. Vaine, et al.
Neurobiology of Disease (2020) Vol. 144, pp. 105032-105032
Open Access | Times Cited: 32
High-throughput virtual screening of potential inhibitors of GPR52 using docking and biased sampling method for Huntington’s disease therapy
Himanshi Gupta, Shakti Sahi
Molecular Diversity (2023)
Closed Access | Times Cited: 10
Minocycline as a prospective therapeutic agent for cancer and non-cancer diseases: a scoping review
Abedeh Rezaei, Amin Moqadami, Mohammad Khalaj‐Kondori
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2835-2848
Closed Access | Times Cited: 9
Metabolism in Huntington’s disease: a major contributor to pathology
Akanksha Singh, Namita Agrawal
Metabolic Brain Disease (2021) Vol. 37, Iss. 6, pp. 1757-1771
Closed Access | Times Cited: 21
Mushroom Polysaccharides as Potential Candidates for Alleviating Neurodegenerative Diseases
Xue Jiang, Siqi Li, Xiangru Feng, et al.
Nutrients (2022) Vol. 14, Iss. 22, pp. 4833-4833
Open Access | Times Cited: 14
Glycation in Huntington’s Disease: A Possible Modifier and Target for Intervention
Inês Caldeira Brás, Annekatrin König, Tiago F. Outeiro
Journal of Huntington s Disease (2019) Vol. 8, Iss. 3, pp. 245-256
Open Access | Times Cited: 25
Immunomodulation in age‐related disorders and nanotechnology interventions
Uday Chintapula, Tanmayee Chikate, Deepsundar Sahoo, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 15, Iss. 1
Closed Access | Times Cited: 11
Diversity and structural‐functional insights of alpha‐solenoid proteins
Paula Nazarena Arrías, Zarifa Osmanli, E G Peralta, et al.
Protein Science (2024) Vol. 33, Iss. 11
Open Access | Times Cited: 2
Pridopidine in the treatment of Huntington’s disease
Magdalena Jabłońska, Klaudyna Grzelakowska, Bartłomiej Wiśniewski, et al.
Reviews in the Neurosciences (2020) Vol. 31, Iss. 4, pp. 441-451
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top